Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer

NCT00456989 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Taxotere
DRUG: Doxil

Sponsor

University of Louisville

Collaborators

[object Object]